ATOPIC DERMATITIS ECZEMA
Clinical trials for ATOPIC DERMATITIS ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS ECZEMA trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill trial aims to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing whether a new oral medication called soquelitinib can safely reduce the rash and itch of moderate to severe eczema (atopic dermatitis). About 200 adults will take either the real pill or a placebo (a dummy pill with no medicine) daily for 12 weeks. Doctors w…
Matched conditions: ATOPIC DERMATITIS ECZEMA
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial offers hope for severe eczema sufferers
Disease control Recruiting nowThis study is testing whether a new drug called IMG-007 can help adults with moderate-to-severe eczema (atopic dermatitis) when standard topical treatments haven't worked well enough. 220 participants will receive either different doses of IMG-007 or a placebo for up to 52 weeks …
Matched conditions: ATOPIC DERMATITIS ECZEMA
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Could less medicine keep eczema under control? trial tests spacing out injections
Disease control Recruiting nowThis study is testing whether adults with atopic eczema (atopic dermatitis) that is already well-controlled can safely take their dupilumab medication less often. Researchers will randomly assign 216 participants to receive their standard injection every 2 weeks, or to try extend…
Matched conditions: ATOPIC DERMATITIS ECZEMA
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC